A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten‐year results

Primary Biliary Cirrhosis

Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 2,015 · see citing works

A One-Year Trial of Lamivudine for Chronic Hepatitis B

Lai, C., Chien, R., Leung, N. W. Y., Chang, T., Guan, R., Tai, D., Ng, K., Wu, P., Dent, J. C., Barber, J., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807093390201 · Cited by 1,750 · see citing works

Prognosis in primary biliary cirrhosis: Model for decision making

Dickson, R. E., Grambsch, P. M., Fleming, T. R., Fisher, L. D., & Langworthy, A. (1989) · Hepatology · doi:10.1002/hep.1840100102 · Cited by 816 · see citing works

A Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary Cirrhosis

Poupon, R. E., Balkau, B., Eschwège, E., Poupon, R., & the UDCA–PBC Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199105303242204 · Cited by 755 · see citing works

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

Lindor, K. D., Dickson, E. R., Baldus, W. P., Jorgensen, R. A., Ludwig, J., Murtaugh, P. A., Harrison, J. M., Wiesner, R. H., Anderson, M. L., Lange, S. M., et al. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90021-3 · Cited by 487 · see citing works

Primary Biliary Cirrhosis

Kaplan, M. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611213352107 · Cited by 455 · see citing works

Randomised controlled trials of ursodeoxycholic‐acid therapy for primary biliary cirrhosis: a meta‐analysis

Goulis, J., Leandro, G., & Burroughs, A. K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11293-x · Cited by 315 · see citing works

A Prospective Trial of Colchicine for Primary Biliary Cirrhosis

Kaplan, M. M., Alling, D. W., Zimmerman, H. J., Wolfe, H. J., Sepersky, R. A., Hirsch, G. S., Elta, G. H., Glick, K., & Eagen, K. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612043152304 · Cited by 313 · see citing works

A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis

COMBES, B., Carithers, R. L., Maddrey, W. C., Lin, D., McDonald, M. F., Wheeler, D. E., Eigenbrodt, E. H., Muñoz, S. J., Rubin, R., Garcia-Tsao, G., et al. (1995) · Hepatology · doi:10.1016/0270-9139(95)90294-5 · Cited by 302 · see citing works

Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial

Parés, A. R., Caballería, L., Rodés, J., Bruguera, M., Rodrigo, L., García-Plaza, A., Berenguer, J., Rodrı́guez-Martı́nez, D., Mercader, J., & Velicia, R. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80216-0 · Cited by 268 · see citing works

Methotrexate induced liver cirrhosis

ZACHARIAE, H., Kragballe, K., & SØGAARD, H. (1980) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1980.tb06553.x · Cited by 255 · see citing works

Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis

Lindor, K., Therneau, T., Jorgensen, R., Malinchoc, M., & Dickson, E. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613058 · Cited by 228 · see citing works

Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis

Poupon, R. E., Bonnand, A.-M., Chrétien, Y., & Poupon, R. (1999) · Hepatology · doi:10.1002/hep.510290603 · Cited by 209 · see citing works

Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid

Angulo, P., Lindor, K. D., Therneau, T. M., Jorgensen, R. A., Malinchoc, M., Kamath, P. S., & Dickson, E. R. (1999) · Liver International · doi:10.1111/j.1478-3231.1999.tb00020.x · Cited by 203 · see citing works

Time course of histological progression in primary biliary cirrhosis

Locke, G. R., Therneau, T. M., Ludwig, J., Dickson, E. R., & Lindor, K. D. (1996) · Hepatology · doi:10.1002/hep.510230108 · Cited by 184 · see citing works

A Prospective Trial of D-Penicillamine in Primary Biliary Cirrhosis

Matloff, D. S., Alpert, E., Resnick, R. H., & Kaplan, M. M. (1982) · New England Journal of Medicine · doi:10.1056/nejm198202113060602 · Cited by 124 · see citing works

Treatment of primary biliary cirrhosis with low-dose weekly methotrexate

Kaplan, M. M., & Knox, T. A. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90085-y · Cited by 107 · see citing works

Low-dose methotrexate is ineffective in primary biliary cirrhosis: Long-term results of a placebo-controlled trial

Hendrickse, M. T., Rigney, E., Giaffer, M. H., Soomro, I. N., Triger, D. R., Underwood, J. C. E., & Gleeson, D. C. (1999) · Gastroenterology · doi:10.1053/gast.1999.0029900400 · Cited by 101 · see citing works

A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis

Poupon, R., Huet, P., Poupon, R., Bonnand, A., van Nhieu, J. T., & Zafrani, E. (1996) · Hepatology · doi:10.1002/hep.510240520 · Cited by 91 · see citing works

Methotrexate-Induced Liver Cirrhosis

ZACHARIAE, H., & SØGAARD, H. (2009) · Dermatologica · doi:10.1159/000248822 · Cited by 87 · see citing works

Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment

Leuschner, M., Dietrich, C. F., You, T., Seidl, C., Raedle, J., Herrmann, G., Ackermann, H., & Leuschner, U. (2000) · Gut · doi:10.1136/gut.46.1.121 · Cited by 81 · see citing works

Characterisation of patients with a complete biochemical response to ursodeoxycholic acid.

Jorgensen, R. A., Dickson, E. R., Hofmann, A. F., Rossi, S. S., & Lindor, K. D. (1995) · Gut · doi:10.1136/gut.36.6.935 · Cited by 77 · see citing works

A randomized double-blind, placebo-controlled trial ursodeoxycholic acid in primary biliary cirrhosis

Combes, B., Carithers, R. L., Maddrey, W. C., Lin, D. P., McDonald, M. F., Wheeler, D. E., Eigenbrodt, E. H., oz, S. J. M., Rubin, R., Garcia-Tsao, G., et al. (1995) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199511000-00024 · Cited by 72 · see citing works

A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis.

Kaplan, M. M., Schmid, C. H., Provenzale, D., Sharma, A., Dickstein, G., & McKusick, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70403-8 · Cited by 64 · see citing works

Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissue

Poupon, R. E., Balkau, B., Guéchot, J., & Heintzmann, F. (1994) · Hepatology · doi:10.1002/hep.1840190314 · Cited by 58 · see citing works

Primary biliary cirrhosis: diagnosis, pathology and pathogenesis.

Scheuer, P. J. (1983) · PubMed · Cited by 51 · see citing works

Primary Biliary Cirrhosis Treated with Low-Dose Oral Pulse Methotrexate

Kaplan, M. M., Knox, T. A., & Arora, S. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-5-429 · Cited by 50 · see citing works

Methotrexate therapy for primary biliary cirrhosis

Bach, N., Bodian, C., Bodenheimer, H. C., Croen, E. C., Berk, P. D., Thung, S. N., Lindor, K. D., Therneau, T., & Schaffner, F. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07173.x · Cited by 41 · see citing works

Ten‐year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double‐blind, placebo‐controlled trial on symptomatic patients

Battezzati, P., Zuin, M., Crosignani, A., Allocca, M., Invernizzi, P., Selmi, C., Villa, E., & Podda, M. (2001) · Alimentary Pharmacology and Therapeutics · doi:10.1046/j.1365-2036.2001.01018.x · Cited by 40 · see citing works

Methotrexate hepatotoxicity and the premature reporting of Mark Twain's death: Both greatly exaggerated

Kaplan, M. M. (1990) · Hepatology · doi:10.1002/hep.1840120427 · Cited by 38 · see citing works

Prognostication in primary biliary cirrhosis: Relevance to the individual patient

Christensen, E. (1989) · Hepatology · doi:10.1002/hep.1840100121 · Cited by 21 · see citing works

Ursodeoxycholic acid for primary biliary cirrhosis: lesson for the future?

Gluud, C. N., & Christensen, E. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00061-7 · Cited by 16 · see citing works

112 The primary biliary cirrhosis (PBC) ursodiol (UDCA) plus methotrexate (MTX) or its placebo study (pumps) - A multicenter randomized trial

COMBES, B., Simerson, S., & Flye, N. L. (2003) · Hepatology · doi:10.1016/s0270-9139(03)80155-6 · Cited by 12 · see citing works

The Canadian Multicenter Double‐blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis

Heathcote, J. E., Cauch-Dudek, K., Walker, V., Bailey, R. J., Blendis, L. M., Ghent, C. N., Michieletti, P., Minuk, G. Y., Pappas, C. S., Scully, L. J., et al. (1994) · Hepatology · doi:10.1002/hep.1840190512 · Cited by 2 · see citing works

Primary biliary cirrhosis

Kaplan, M. M., & Gershwin, M. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043898 · Cited by 1,144 · see citing works

Primary biliary cirrhosis # †

Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099 · see citing works

Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913 · see citing works

Clinical evidence for the regression of liver fibrosis

Ellis, E. L., & Mann, D. A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.09.024 · Cited by 411 · see citing works

Mechanisms of liver fibrosis

Tsukada, S., Parsons, C. J., & Rippe, R. A. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.014 · Cited by 353 · see citing works

The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease

Lim, Y., & Kim, W. R. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.007 · Cited by 316 · see citing works

Primary biliary cirrhosis: A 2010 update

Poupon, R. Y. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.11.027 · Cited by 272 · see citing works

Colchicine in clinical medicine. A guide for internists

Cocco, G., Chu, D. C. C., & Pandolfi, S. (2010) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2010.09.010 · Cited by 222 · see citing works

Risk of liver disease in methotrexate treated patients

Conway, R., & Carey, J. J. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i26.1092 · Cited by 170 · see citing works

Current and Future Anti-Fibrotic Therapies for Chronic Liver Disease

Rockey, D. C. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.011 · Cited by 163 · see citing works

Reversal of liver cirrhosis: current evidence and expectations

Jung, Y. K., & Yim, H. J. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.268 · Cited by 152 · see citing works

Ursodeoxycholic Acid for the Treatment of Primary Biliary Cirrhosis

Lindor, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmct074694 · Cited by 115 · see citing works

Antifibrotic therapy in chronic liver disease

Rockey, D. C. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00445-8 · Cited by 113 · see citing works

Colchicine for prevention of cardiovascular events

Hemkens, L. G., Ewald, H., Gloy, V., Arpagaus, A., Olu, K. K., Nidorf, M., Glinz, D., Nordmann, A. J., & Briel, M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011047.pub2 · Cited by 93 · see citing works

Translating an Understanding of the Pathogenesis of Hepatic Fibrosis to Novel Therapies

Rockey, D. C. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.01.005 · Cited by 80 · see citing works

Pharmacological interventions for primary biliary cholangitis

Saffioti, F., Gurusamy, K. S., Eusebi, L. H., Tsochatzis, E. A., Davidson, B. R., & Thorburn, D. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011648.pub2 · Cited by 54 · see citing works

Methotrexate for primary biliary cirrhosis

Giljača, V., Poropat, G., Štimac, D., & Gluud, C. N. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004385.pub3 · Cited by 53 · see citing works

Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone

Rabahi, N., Chrétien, Y., Gaouar, F., Wendum, D., Serfaty, L., Chazouillères, O., Corpechot, C., & Poupon, R. Y. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2010.02.004 · Cited by 53 · see citing works

Old and new treatments for primary biliary cholangitis

Chascsa, D. M. H., Carey, E. J., & Lindor, K. D. (2017) · Liver International · doi:10.1111/liv.13294 · Cited by 50 · see citing works

Treatment of autoimmune liver disease: current and future therapeutic options

Trivedi, P. J., & Hirschfield, G. M. (2013) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622313478646 · Cited by 49 · see citing works

Cholestasis and cholestatic syndromes

OʼLeary, J. G., & Pratt, D. S. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3280d942d8 · Cited by 45 · see citing works

Hepatic Fibrosis and Cirrhosis

Rockey, D. C. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch105 · Cited by 41 · see citing works

Primary biliary cirrhosis in adults

Momah, N., & Lindor, K. D. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2014.888950 · Cited by 33 · see citing works

Colchicine or Methotrexate, With Ursodiol, Are Effective After 20 Years in a Subset of Patients With Primary Biliary Cirrhosis

Leung, J., Bonis, P. A., & Kaplan, M. M. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.05.010 · Cited by 32 · see citing works

Association between rheumatoid arthritis and primary biliary cirrhosis

Caramella, C., Avouac, J., Sogni, P., Puéchal, X., Kahan, A., & Allanore, Y. (2007) · Joint Bone Spine · doi:10.1016/j.jbspin.2006.06.012 · Cited by 30 · see citing works

Natural history and management of primary biliary cirrhosis

Kumagi, T., & Al‐Harthy, N. (2012) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s25998 · Cited by 30 · see citing works

Methotrexate in Patients with Primary Biliary Cirrhosis Who Respond Incompletely to Treatment With Ursodeoxycholic Acid

Kaplan, M. M., Bonder, A., Ruthazer, R., & Bonis, P. A. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1291-5 · Cited by 29 · see citing works

Current pharmacotherapy for cholestatic liver disease

Carey, E. J., & Lindor, K. D. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.736491 · Cited by 29 · see citing works

Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy

Babatin, M. A., Sanai, F. M., & Swain, M. G. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03048.x · Cited by 29 · see citing works

Emerging therapies for PBC

Chascsa, D. M. H., & Lindor, K. D. (2020) · Journal of Gastroenterology · doi:10.1007/s00535-020-01664-0 · Cited by 28 · see citing works

Network Meta-Analysis of Randomized Controlled Trials

Zhu, G., Shi, K., Huang, S., Huang, G., Lin, Y.-Q., Zhou, Z., Braddock, M., Chen, Y., & Zheng, M. (2015) · Medicine · doi:10.1097/md.0000000000000609 · Cited by 27 · see citing works

Medical Treatment of Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis

Rust, C., & Beuers, U. H. (2005) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:28:2:135 · Cited by 26 · see citing works

Galactosylated Pro–Drug of Ursodeoxycholic Acid: Design, Synthesis, Characterization, and Pharmacological Effects in a Rat Model of Estrogen-Induced Cholestasis

Guida, F., Pirozzi, C., Magliocca, S., Santoro, A. N., Lama, A., Russo, R., Nieddu, M., Burrai, L., Boatto, G., Mollica, M. P., et al. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00626 · Cited by 20 · see citing works

Methotrexate for primary biliary cirrhosis

Gong, Y., & Gluud, C. N. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004385.pub2 · Cited by 20 · see citing works

Ultrastructural changes in rat livers perfused in vitro and in vivo with a high dose of methotrexate.

Al‐Ali, S., Hassan, I. M., & Sadek, S. (2005) · PubMed · doi:10.14670/hh-20.1131 · Cited by 19 · see citing works

Psoriatic arthritis, methotrexate and the liver--are rheumatologists putting their patients at risk?

Lindsay, K., & Gough, A. (2008) · Rheumatology · doi:10.1093/rheumatology/ken158 · Cited by 19 · see citing works

Hepatic Fibrosis and Cirrhosis

Rockey, D. C., & Friedman, S. L. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-3258-8.50011-5 · Cited by 19 · see citing works

Primary biliary cirrhosis: From bench to bedside

Kouroumalis, E. (2015) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v6.i3.32 · Cited by 17 · see citing works

Role of Methotrexate in the Treatment of Chronic Cholestatic Disorders

Novak, K. L., & Swain, M. G. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.11.011 · Cited by 17 · see citing works

Hepatic Fibrosis and Cirrhosis

Rockey, D. C., & Friedman, S. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00005-x · Cited by 13 · see citing works

Addressing Liver Fibrosis with Liposomes Targeted to Hepatic Stellate Cells

Adrian, J. E., Poelstra, K., & Kamps, J. A. A. M. (2007) · Journal of Liposome Research · doi:10.1080/08982100701528047 · Cited by 13 · see citing works

Treatment with immunosuppressives in patients with primary biliary cirrhosis who fail to respond to ursodiol†

Kaplan, M. M., & Poupon, R. Y. (2009) · Hepatology · doi:10.1002/hep.22831 · Cited by 13 · see citing works

Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysis

Zhu, G., Huang, S., Huang, G., Wang, L., Lin, Y.-Q., Wu, Y.-M., Shi, K., Wang, J., Zhou, Z., Braddock, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4528 · Cited by 12 · see citing works

Successful treatment of primary biliary cirrhosis with etanercept in a patient with rheumatoid arthritis

Kubo, S., Iwata, S., Saito, K., & Tanaka, Y. (2011) · Joint Bone Spine · doi:10.1016/j.jbspin.2011.04.014 · Cited by 11 · see citing works

Cholestasis and cholestatic syndromes

Pratt, D. S. (2005) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000159819.01403.39 · Cited by 10 · see citing works

The gut-liver axis in cholangiopathies: focus on bile acid based pharmacological treatment

Cariello, M., Gadaleta, R. M., & Moschetta, A. (2022) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000807 · Cited by 9 · see citing works

Primary Biliary Cirrhosis

Lindor, K. D., & Levy, C. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00041-3 · Cited by 8 · see citing works

Review: Current status of therapy in autoimmune liver disease

Hirschfield, G. M., Al‐Harthy, N., & Heathcote, E. J. (2009) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x08098966 · Cited by 7 · see citing works

Trials in primary biliary cirrhosis: Need for the right drugs at the right time†

Poupon, R. Y. (2004) · Hepatology · doi:10.1002/hep.20188 · Cited by 7 · see citing works

Management of Autoimmune and Cholestatic Liver Disorders

Krok, K. L., & Muñoz, S. J. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.02.011 · Cited by 6 · see citing works

3α-6α-Dihydroxy-7α-fluoro-5β-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17α-ethynyl-estradiol-induced cholestasis in rats

Clerici, C., Castellani, D., Asciutti, S., Pellicciari, R., Setchell, K. D. R., O’Connell, N. C., Sadeghpour, B. M., Camaioni, E., Fiorucci, S., Renga, B., et al. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.12.017 · Cited by 6 · see citing works

Primary Biliary Cirrhosis

Clark, V., & Levy, C. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-118-5_3 · Cited by 5 · see citing works

Facial symmetry evaluation after experimentally displaced condylar process fracture in methotrexate treated rats

Cavalcanti, S., Côrrea, L., & Luz, J. G. D. C. (2012) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-86502012000300002 · Cited by 4 · see citing works

The Treatment of Hepatic Fibrosis: Reversal of the Underlying Disease Process.

Servin-Abad, L. A., & Schiff, E. R. (2006) · PubMed Central · Cited by 4 · see citing works

Primary Biliary Cirrhosis

Talwalkar, J. A., & Lindor, K. D. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-3258-8.50046-2 · Cited by 4 · see citing works

Basic immunosuppressive drugs outside solid organ transplantation

Braun, F., & Behrend, M. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.3.267 · Cited by 3 · see citing works

Primary Biliary Cirrhosis associated with rheumatoid arthritis : two case reports in China

Liu, J., Zhou, X., Han, Y., Li, Y., Wang, J., & Fan, D. (2007) · Cited by 3 · see citing works

Immunosuppressive Therapy in Immune-Mediated Liver Disease in the Non-Transplanted Patient

Abhyankar, A., Tapper, E. B., & Bonder, A. (2013) · Pharmaceuticals · doi:10.3390/ph7010018 · Cited by 2 · see citing works

Oxidative Stress in Autoimmune Liver Disease

Domínguez, V. M., Vilar‐Gómez, E., Garcı́a-Buey, L., & Moreno‐Otero, R. (2015) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-319-15539-5_14 · Cited by 2 · see citing works

Cirrhose biliaire primitive

Poupon, R. Y. (2010) · EMC - Hépatologie · doi:10.1016/s1155-1976(10)46408-6 · Cited by 2 · see citing works

A Case of Antimitochondrial Antibody Negative Primary Biliary Cirrhosis from Bangladesh and Review of Literature

Begum, R., Mamun, A. A., Saha, B. K., Hossain, S. M. S., & Das, D. C. (2015) · Euroasian Journal of Hepato-Gastroenterology · doi:10.5005/jp-journals-10018-1150 · Cited by 2 · see citing works

Primary Biliary Cholangitis

Sclair, S. N., & Levy, C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00042-2 · Cited by 2 · see citing works

Cirrhose biliaire primitive

Poupon, R. Y. (2010) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(10)54652-0 · Cited by 2 · see citing works

Primary biliary cirrhosis

Poupon, R. Y. (2012) · Wiley eBooks · doi:10.1002/9781118321386.ch86 · Cited by 2 · see citing works

Investigating the therapeutic potential of low-level laser therapy in mitigating liver fibrosis

Mohamed, A. E., Mahmoud, A. M., Mohamed, W. R., & Mohamed, T. A. (2024) · Laser Innovations for Research and Applications. · doi:10.21608/lira.2024.357511 · Cited by 1 · see citing works

ADVANCES IN TRANSLATIONAL SCIENCE

Sellin, J. H., Murthy, S. K., Goetz, M., Hoffman, A. W., & Kießlich, R. (2012) · Cited by 1 · see citing works

Ursodeoxycholic Acid in Liver Cirrhosis: A Chinese Perspective

Gao, W., Li, Z., Chu, H., Yuan, H., Hu, L., Yao, L., Zhang, L. R., Wang, W., Lin, R., & Yang, L. (2022) · Springer eBooks · doi:10.1007/978-981-19-2615-0_6 · Cited by 1 · see citing works

Pharmacological treatments for primary biliary cirrhosis: a network meta-analysis

Gurusamy, K. S., Tsochatzis, E. A., Davidson, B. R., & Thorburn, D. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011648 · Cited by 1 · see citing works

Cirrosis biliar primaria

Poupon, R. Y. (2010) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(10)70489-x · Cited by 1 · see citing works

Association polyarthrite rhumatoïde et cirrhose biliaire primitive

Caramella, C., Avouac, J., Sogni, P., Puéchal, X., Kahan, A., & Allanore, Y. (2007) · Revue du Rhumatisme · doi:10.1016/j.rhum.2006.06.017 · Cited by 1 · see citing works

Primary Biliary Cholangitis (Formerly Primary Biliary Cirrhosis)

Trivedi, P. J., & Hirschfield, G. M. (2019) · Wiley eBooks · doi:10.1002/9781119211419.ch38 · Cited by 1 · see citing works

Changing outcomes with antiviral or antifibrotic therapies

Esmat, G., & Raziky, M. E. (2015) · Wiley eBooks · doi:10.1002/9781118412640.ch24

Addressing liver fibrosis with lipid-based drug carriers targeted to hepatic stellate cells

Adrian, J. E. (2006) · University of Groningen research database (University of Groningen / Centre for Information Technology)

Primary Biliary Cirrhosis

Dancygier, H. (2009) · Springer eBooks · doi:10.1007/978-3-642-04519-6_19

Efficacité de l’étanercept dans une cirrhose biliaire primitive associée à une polyarthrite rhumatoïde

Kubo, S., Iwata, S., Saito, K., & Tanaka, Y. (2011) · Revue du Rhumatisme · doi:10.1016/j.rhum.2011.04.012

Cirrosi biliare primitiva

Poupon, R. Y. (2011) · EMC - AKOS - Trattato di Medicina · doi:10.1016/s1634-7358(11)70560-5

Autoimmune liver diseases: internist’s guide from bench to bedside

Visconti, M. (2015) · Italian Journal of Medicine · doi:10.4081/itjm.2015.508

A case of symptomatic primary biliary cirrhosis complicated by Behçet' s disease which emerged with joint swelling

Sakane, S., Miyagi, T., Azukizawa, H., Sakamori, R., Yakushijin, T., Hikita, H., Oze, T., Kamada, Y., Yoshida, Y., Tatsumi, T., et al. (2015) · Kanzo · doi:10.2957/kanzo.56.575

Challenges and opportunities in the management of portal hypertension

Patanwala, I. (2015)

Colchicine or Methotrexate Plus UDCA for Primary Biliary Cirrhosis: 10-Year Results

Flora, K. D. (2004) · Journal watch · doi:10.1056/jg200407270000003

Primary Biliary Cholangitis

Carey, E. J., & Levy, C. (2018) · Clinics in Liver Disease · doi:10.1016/s1089-3261(18)30044-8

Le malattie infiammatorie immuno-mediate (IMID) di interesse internistico: fisiopatologia, aspetti clinici e prospettive di terapia

Fontanella, A., Nardi, R., Masina, M., & Uomo, G. (2017) · Italian Journal of Medicine · doi:10.4081/itjm.q.2017.7

Association polyarthrite rhumatoïde et cirrhose biliaire primitive Association between rheumatoid arthritis and primary biliary cirrhosis

Caramella, C., Avouac, J., Sogni, P., Puéchal, X., Kahan, A., & Allanore, Y. (2007)

Biliary cell lineage. Clinic (diagnosis, treatment).

Sakisaka, S. (2004) · Kanzo · doi:10.2957/kanzo.45.661

Treatment of primary biliary cirrhosis: current standards

Poupon, R. Y., Corpechot, C., Carrat, F., Chrétien, Y., & Poupon, R. E. (2007) · Springer eBooks · doi:10.1007/1-4020-2916-0_17

Cholangitis and cholangiodysplasia

(2006) · Springer eBooks · doi:10.1007/3-540-28977-1_32

Primary Biliary Cholangitis

van der Meer, A. J., & Trivedi, P. J. (2026) · Wiley eBooks · doi:10.1002/9781394360031.ch20

Methotrexate and colchicine in the treatment of primary biliary cirrhosis

Kaplan, M. M. (1998) · Springer eBooks · doi:10.1007/978-94-011-4884-9_15

Colchicine or Methotrexate Plus UDCA for Primary Biliary Cirrhosis: 10-Year Results

Flora, K. D. (2004) · Journal watch · doi:10.1056/jg200407270000003

Ten‐year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double‐blind, placebo‐controlled trial on symptomatic patients

Battezzati, P., Zuin, M., Crosignani, A., Allocca, M., Invernizzi, P., Selmi, C., Villa, E., & Podda, M. (2001) · Alimentary Pharmacology and Therapeutics · doi:10.1046/j.1365-2036.2001.01018.x · Cited by 40 · see citing works

ORIGINAL ARTICLES—LIVER, PANCREAS, AND BILIARY TRACT Colchicine or Methotrexate, With Ursodiol, Are Effective After 20 Years in a Subset of Patients With Primary Biliary Cirrhosis

Leung, J., Bonis, P. A., & Kaplan, M. M. (2011)

Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate

Lee, Y., & Kaplan, M. M. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07182.x · Cited by 25 · see citing works